Officials responsible for childhood immunizations insist that the
additional vaccines were necessary to protect infants from disease and that
thimerosal is still essential in developing nations, which, they often claim,
cannot afford the single-dose vials that don't require a preservative. Dr.
Paul Offit, one of CDC's top vaccine advisors, told me, "I think if we really
have an influenza pandemic -- and certainly we will in the next 20 years,
because we always do -- there's no way on God's earth that we immunize 280
million people with single-dose vials. There has to be multidose vials."
But while public-health officials may have been well-intentioned, many of
those on the CDC advisory committee who backed the additional vaccines had
close ties to the industry. Dr. Sam Katz, the committee's chair, was a
paid consultant for most of the major vaccine makers and shares a patent on a
measles vaccine with Merck, which also manufactures the hepatitis B vaccine.
Dr. Neal Halsey, another committee member, worked as a researcher for the
vaccine companies and received honoraria from Abbott Labs for his research on
the hepatitis B vaccine.
Indeed, in the tight circle of scientists who work on vaccines, such conflicts
of interest are common. Rep. Burton says that the CDC "routinely allows
scientists with blatant conflicts of interest to serve on intellectual
advisory committees that make recommendations on new vaccines," even though
they have "interests in the products and companies for which they are supposed
to be providing unbiased oversight." The House Government Reform Committee
discovered that four of the eight CDC advisors who approved guidelines for a
rotavirus vaccine "had financial ties to the pharmaceutical companies that
were developing different versions of the vaccine."
Offit, who shares a patent on one of the vaccines, acknowledged to me that he
"would make money" if his vote eventually leads to a marketable product. But
he dismissed my suggestion that a scientist's direct financial stake in CDC
approval might bias his judgment. "It provides no conflict for me," he
insists. "I have simply been informed by the process, not corrupted by it.
When I sat around that table, my sole intent was trying to make
recommendations that best benefited the children in this country. It's
offensive to say that physicians and public-health people are in the pocket of
industry and thus are making decisions that they know are unsafe for children.
It's just not the way it works."
Other vaccine scientists and regulators gave me similar assurances. Like Offit,
they view themselves as enlightened guardians of children's health, proud of
their "partnerships" with pharmaceutical companies, immune to the seductions
of personal profit, besieged by irrational activists whose anti-vaccine
campaigns are endangering children's health. They are often resentful of
questioning. "Science," says Offit, "is best left to scientists."
Still, some government officials were alarmed by the apparent conflicts of
interest. In his e-mail to CDC administrators in 1999, Paul Patriarca of the
FDA blasted federal regulators for failing to adequately scrutinize the danger
posed by the added baby vaccines. "I'm not sure there will be an easy way out
of the potential perception that the FDA, CDC and immunization-policy bodies
may have been asleep at the switch re: thimerosal until now," Patriarca wrote.
The close ties between regulatory officials and the pharmaceutical industry,
he added, "will also raise questions about various advisory bodies regarding
aggressive recommendations for use" of thimerosal in child vaccines.
If federal regulators and government scientists failed to grasp the potential
risks of thimerosal over the years, no one could claim ignorance after the
secret meeting at Simpsonwood. But rather than conduct more studies to test
the link to autism and other forms of brain damage, the CDC placed politics
over science. The agency turned its database on childhood vaccines -- which
had been developed largely at taxpayer expense -- over to a private agency,
America's Health Insurance Plans, ensuring that it could not be used for
additional research. It also instructed the Institute of Medicine, an advisory
organization that is part of the National Academy of Sciences, to produce a
study debunking the link between thimerosal and brain disorders.
The CDC "wants us to declare, well, that these things are pretty safe," Dr.
Marie McCormick, who chaired the IOM's Immunization Safety Review Committee,
told her fellow researchers when they first met in January 2001. "We are not
ever going to come down that [autism] is a true side effect" of thimerosal
exposure.
According to transcripts of the meeting, the committee's chief staffer,
Kathleen Stratton, predicted that the IOM would conclude that the evidence was
"inadequate to accept or reject a causal relation" between thimerosal and
autism. That, she added, was the result "Walt wants" -- a reference to Dr.
Walter Orenstein, director of the National Immunization Program for the CDC.
For those who had devoted their lives to promoting vaccination, the
revelations about thimerosal threatened to undermine everything they had
worked for. "We've got a dragon by the tail here," said Dr. Michael Kaback,
another committee member. "The more negative that [our] presentation is, the
less likely people are to use vaccination, immunization -- and we know what
the results of that will be. We are kind of caught in a trap. How we work our
way out of the trap, I think is the charge."
Even in public, federal officials made it clear that their primary goal in
studying thimerosal was to dispel doubts about vaccines. "Four current studies
are taking place to rule out the proposed link between autism and thimerosal,"
Dr. Gordon Douglas, then-director of strategic planning for vaccine research
at the National Institutes of Health, assured a Princeton University gathering
in May 2001. "In order to undo the harmful effects of research claiming to
link the [measles] vaccine to an elevated risk of autism, we need to conduct
and publicize additional studies to assure parents of safety." Douglas
formerly served as president of vaccinations for Merck, where he ignored
warnings about thimerosal's risks.
In May of last year, the Institute of Medicine issued its final report. Its
conclusion: There is no proven link between autism and thimerosal in vaccines.
Rather than reviewing the large body of literature describing the toxicity of
thimerosal, the report relied on four disastrously flawed epidemiological
studies examining European countries, where children received much smaller
doses of thimerosal than American kids. It also cited a new version of the
Verstraeten study, published in the journal Pediatrics, that had been reworked
to reduce the link between thimerosal and autism. The new study included
children too young to have been diagnosed with autism and overlooked others
who showed signs of the disease. The IOM declared the case closed and -- in a
startling position for a scientific body -- recommended that no further
research be conducted.
The report may have satisfied the CDC, but it convinced no one. Rep. David
Weldon, a Republican physician from Florida who serves on the House Government
Reform Committee, attacked the Institute of Medicine, saying it relied on a
handful of studies that were "fatally flawed" by "poor design" and failed to
represent "all the available scientific and medical research." CDC officials
are not interested in an honest search for the truth, Weldon told me, because
"an association between vaccines and autism would force them to admit that
their policies irreparably damaged thousands of children. Who would want to
make that conclusion about themselves?"
Under pressure from Congress, parents and a few of its own panel members, the
Institute of Medicine reluctantly convened a second panel to review the
findings of the first. In February, the new panel, composed of different
scientists, criticized the earlier panel for its lack of transparency and
urged the CDC to make its vaccine database available to the public.
So far, though, only two scientists have managed to gain access. Dr. Mark
Geier, president of the Genetics Center of America, and his son, David, spent
a year battling to obtain the medical records from the CDC. Since August 2002,
when members of Congress pressured the agency to turn over the data, the
Geiers have completed six studies that demonstrate a powerful correlation
between thimerosal and neurological damage in children. One study, which
compares the cumulative dose of mercury received by children born between 1981
and 1985 with those born between 1990 and 1996, found a "very significant
relationship" between autism and vaccines. Another study of educational
performance found that kids who received higher doses of thimerosal in
vaccines were nearly three times as likely to be diagnosed with autism and
more than three times as likely to suffer from speech disorders and mental
retardation. Another soon-to-be-published study shows that autism rates are in
decline following the recent elimination of thimerosal from most vaccines.
As the federal government worked to prevent scientists from studying vaccines,
others have stepped in to study the link to autism. In April, reporter Dan
Olmsted of UPI undertook one of the more interesting studies himself.
Searching for children who had not been exposed to mercury in vaccines -- the
kind of population that scientists typically use as a "control" in experiments
-- Olmsted scoured the Amish of Lancaster County, Penn., who refuse to
immunize their infants. Given the national rate of autism, Olmsted calculated
that there should be 130 autistics among the Amish. He found only four. One
had been exposed to high levels of mercury from a power plant. The other three
-- including one child adopted from outside the Amish community -- had
received their vaccines.
At the state level, many officials have also conducted in-depth reviews of
thimerosal. While the Institute of Medicine was busy whitewashing the risks,
the Iowa Legislature was carefully combing through all of the available
scientific and biological data. "After three years of review, I became
convinced there was sufficient credible research to show a link between
mercury and the increased incidences in autism," says state Sen. Ken Veenstra,
a Republican who oversaw the investigation. "The fact that Iowa's 700 percent
increase in autism began in the 1990s, right after more and more vaccines were
added to the children's vaccine schedules, is solid evidence alone." Last
year, Iowa became the first state to ban mercury in vaccines, followed by
California. Similar bans are now under consideration in 32 other states.
But instead of following suit, the FDA continues to allow manufacturers to
include thimerosal in scores of over-the-counter medications as well as
steroids and injected collagen. Even more alarming, the government continues
to ship vaccines preserved with thimerosal to developing countries -- some of
which are now experiencing a sudden explosion in autism rates. In China, where
the disease was virtually unknown prior to the introduction of thimerosal by
U.S. drug manufacturers in 1999, news reports indicate that there are now more
than 1.8 million autistics. Although reliable numbers are hard to come by,
autistic disorders also appear to be soaring in India, Argentina, Nicaragua
and other developing countries that are now using thimerosal-laced vaccines.
The World Health Organization continues to insist thimerosal is safe, but it
promises to keep the possibility that it is linked to neurological disorders
"under review."
I devoted time to study this issue because I believe that this is a moral
crisis that must be addressed. If, as the evidence suggests, our public-health
authorities knowingly allowed the pharmaceutical industry to poison an entire
generation of American children, their actions arguably constitute one of the
biggest scandals in the annals of American medicine. "The CDC is guilty of
incompetence and gross negligence," says Mark Blaxill, vice president of Safe
Minds, a nonprofit organization concerned about the role of mercury in
medicines. "The damage caused by vaccine exposure is massive. It's bigger than
asbestos, bigger than tobacco, bigger than anything you've ever seen." It's
hard to calculate the damage to our country -- and to the international
efforts to eradicate epidemic diseases -- if Third World nations come to
believe that America's most heralded foreign-aid initiative is poisoning their
children. It's not difficult to predict how this scenario will be interpreted
by America's enemies abroad. The scientists and researchers -- many of them
sincere, even idealistic -- who are participating in efforts to hide the
science on thimerosal claim that they are trying to advance the lofty goal of
protecting children in developing nations from disease pandemics. They are
badly misguided. Their failure to come clean on thimerosal will come back
horribly to haunt our country and the world's poorest populations.
This story has been corrected since it was originally published.
- - - - - - - - - - - -
About the writer:
Robert F. Kennedy Jr. is senior attorney for the Natural Resources Defense
Council, chief prosecuting attorney for Riverkeeper and president of
Waterkeeper Alliance. He is the co-author of "The Riverkeepers."
Send us a Letter to the Editor:
http://www.salon.com/about/letters/index.html
Secrets and lies:
Is the astonishing rise in autism a medical mystery or a pharmaceutical shame?
By Lesli Mitchell 08/02/00
http://dir.salon.com/mwt/feature/2000/08/02/autism/index.html?sid=923233
06/03/05, 23400 bytes [ Need paid subscription to read. ]
Salon Media Group, Inc.
101 Spear Street, Suite 203
San Francisco, CA 94105
Telephone 415 645-9200 | Fax 415 645-9204
*************************************************************
http://www.nrdc.org/
nrdcinfo@nrdc.org
http://www.nrdc.org/health/default.asp Toxic chemicals and health
Natural Resources Defense Council
40 West 20th Street
New York, NY 10011
Telephone: (212) 727-2700
Fax: (212) 727-1773
1200 New York Ave., NW, Suite 400, Washington, DC 20005, 202-289-6868
111 Sutter St., 20th floor, San Francisco, CA 94104, 415-875-6100
1314 Second Street, Santa Monica, CA 90401, 310-434-2300
************************************************************
http://www.autisminfo.com/ middlebrooks@cfl.rr.com
6-Year Anniversary!
As the Summer of 2004 approaches, AutismInfo has surpassed 1 million visitors!
Since inception, in November of 1998, AutismInfo.com has grown to become one of the most popular, and often visited autism sites on the internet.
Founded by Merritt Island, Florida residents Jenny and Brad Middlebrook, the Site provides information on autism treatments and therapies to parents, teachers, therapists and doctors. Brad Middlebrook describes one goal of "providing balanced information to parents of newly diagnosed kids."
To date, the site, maintained from the Middlebrook's home in Merritt Island, Florida, has answered over 2,000 email questions from persons around the world. "We have provided information to parents in Kenya, Russia, Singapore and around the United States." Middlebrook says, "we try to update the site daily, and answer email questions the same day as we receive them.
The site is an informational site dedicated to providing current and useful information on autism, and does not raise money or revenues from advertising. The layout, site design and maintenance are done by Brad Middlebrook.
The Middlebrooks are parents of a seven year-old child with autism. Their daughter, who attends a small private school with a school aid, is performing age-appropriately in academics. The Middlebrook's plan on her going to second grade next year independently.